Canada
· Delayed Price · Currency is CAD Oncolytics Biotech Statistics
Total Valuation
TSX:ONC has a market cap or net worth of CAD 69.28 million. The enterprise value is 54.40 million.
| Market Cap | 69.28M |
| Enterprise Value | 54.40M |
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:ONC has 86.60 million shares outstanding. The number of shares has increased by 13.10% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 86.60M |
| Shares Change (YoY) | +13.10% |
| Shares Change (QoQ) | +0.72% |
| Owned by Insiders (%) | 3.52% |
| Owned by Institutions (%) | 1.54% |
| Float | 83.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 11.58 |
| P/TBV Ratio | 11.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.72 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.00 |
Financial Position
The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.82 |
| Quick Ratio | 2.39 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.04 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -189.05% and return on invested capital (ROIC) is -124.82%.
| Return on Equity (ROE) | -189.05% |
| Return on Assets (ROA) | -74.11% |
| Return on Invested Capital (ROIC) | -124.82% |
| Return on Capital Employed (ROCE) | -259.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.13M |
| Employee Count | 28 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.05% in the last 52 weeks. The beta is 1.55, so TSX:ONC's price volatility has been higher than the market average.
| Beta (5Y) | 1.55 |
| 52-Week Price Change | -48.05% |
| 50-Day Moving Average | 0.93 |
| 200-Day Moving Average | 1.26 |
| Relative Strength Index (RSI) | 46.34 |
| Average Volume (20 Days) | 61,294 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -34.98M |
| Pretax Income | -31.58M |
| Net Income | -31.71M |
| EBITDA | -34.88M |
| EBIT | -34.98M |
| Earnings Per Share (EPS) | -0.41 |
Balance Sheet
The company has 15.94 million in cash and 1.06 million in debt, giving a net cash position of 14.88 million or 0.17 per share.
| Cash & Cash Equivalents | 15.94M |
| Total Debt | 1.06M |
| Net Cash | 14.88M |
| Net Cash Per Share | 0.17 |
| Equity (Book Value) | 5.98M |
| Book Value Per Share | 0.07 |
| Working Capital | 12.19M |
Cash Flow
In the last 12 months, operating cash flow was -26.97 million and capital expenditures -239,000, giving a free cash flow of -27.21 million.
| Operating Cash Flow | -26.97M |
| Capital Expenditures | -239,000 |
| Free Cash Flow | -27.21M |
| FCF Per Share | -0.31 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:ONC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.10% |
| Shareholder Yield | -13.10% |
| Earnings Yield | -45.77% |
| FCF Yield | -39.27% |
Stock Splits
The last stock split was on May 25, 2018. It was a reverse split with a ratio of 0.105263.
| Last Split Date | May 25, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.105263 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |